Previous Article | Next Article ![]()
Journal of Bacteriology, June 2005, p. 3980-3989, Vol. 187, No. 12
0021-9193/05/$08.00+0 doi:10.1128/JB.187.12.3980-3989.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institute for Oral Biology, Center for Dental-, Oral Medicine and Maxillofacial Surgery, University of Zürich, Zürich, Switzerland
Received 16 November 2004/ Accepted 14 March 2005
|
|
|---|
|
|
|---|
Bacteriocins from gram-positive bacteria have been classified into three groups: class I bacteriocins contain the posttranslationally modified bacteriocins or lantibiotics, class II comprise small nonmodified, heat-stable peptide bacteriocins, and class III bacteriocins contain large, heat-labile proteins (21). Class II bacteriocins can be further divided into two groups: those that resemble the antilisterial bacteriocin pediocin from Pediococcus species (class IIA) and those that are composed of two peptides (class IIB). The class II bacteriocins are synthesized as prepeptides that contain a leader peptide with two glycine residues at the cleavage site. The mature peptide is cleaved off from the leader peptide after these two glycine residues and released in the medium by an ABC transporter. The class II bacteriocins act on other organisms by insertion in the membrane, causing formation of pores that perturb the membrane potential. Bacteriocin-producing organisms are resistant to their own bacteriocins through the action of immunity proteins.
Most of the bacteriocins from S. mutans characterized up to now belong to the group I lantibiotics. Production of two of these, mutacin I and mutacin 1140, appears to be dependent on the culture conditions, since they could be detected only after growth on agar or agarose-containing medium (10, 27). A nonlantibiotic class IIB bacteriocin, mutacin IV, was purified from S. mutans strain UA140, which also produces the lantibiotic mutacin I (27). Whereas mutacin I could be produced only when cells were grown on solid medium, mutacin IV was produced in liquid culture exclusively. Mutacin IV is encoded by the nlmA and nlmB genes, which are probably organized in an operon.
Expression of class II bacteriocins generally requires an inducer peptide pheromone and a two-component signal transduction system (TCSTS) (20). The TCSTS is composed of a histidine protein kinase that serves to sense the presence of the peptide outside of the cell and transmits the signal over the membrane to a response regulator that activates transcription of the target genes. In many cases, these systems are autoregulated (20). Related two-component regulatory systems are required for competence development in streptococci. In S. mutans, development of competence is under the control of the comCDE system, where comC encodes the precursor of the pheromone competence-stimulating peptide (CSP) and comD and comE encode the histidine kinase sensor and response regulator, respectively (15). The precursor of CSP is processed and exported through an ATP-binding cassette transporter and an accessory protein, which are encoded by comA and comB, respectively (37).
In this study, it is shown that expression of S. mutans nlmAB, encoding mutacin IV, and that of other class IIB bacteriocins and associated genes are induced upon addition of CSP and that inactivation of the two-component regulatory system required for competence development abolishes the production of bacteriocins.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Primers used for construction of mutants and lacZ fusion strains
|
|
View this table: [in a new window] |
TABLE 2. S. mutans strains used in this study
|
was used as a host for plasmids and grown in LB medium. When required, antibiotics were added at the following final concentrations: erythromycin, 200 µg/ml; kanamycin, 50 µg/ml. DNA manipulations. Plasmid DNA purification from E. coli, restriction enzyme digestion, agarose gel electrophoresis, DNA ligation, and transformation of E. coli were carried out using standard methods (3). Chromosomal DNA from S. mutans was isolated by using the Genelute bacterial genomic DNA kit (Sigma, Buchs, Switzerland).
Construction of lacZ fusion strains. To generate a chromosomal nlmAB'-lacZ fusion, a fragment internal to the nlmAB genes (bp 205 to bp 614 [27]) was amplified by PCR using the primers nlmAB1 and nlmAB2 (Table 1) and chromosomal DNA from OMZ1001. The PCR fragment was digested with BamHI and EcoRI and cloned into the vector pSF151 (31) to give plasmid pOMZ46. Subsequently, a BamHI fragment harboring a promoterless lacZ gene (11) was inserted downstream of nlmAB in the same direction of transcription, which resulted in plasmid pOMZ47. The plasmid was then introduced into S. mutans OMZ1001 by transformation (23) followed by selection for kanamycin resistance. Since pSF151 and its derivatives cannot replicate in S. mutans, kanamycin-resistant colonies must have arisen from single crossover and contain a lacZ fusion to nlmAB. The resulting strain was designated OMZ1008.
For the construction of the lacZ fusions with the bsmA, bsmE, bsmHI, bsmK, immB, and immA genes of S. mutans, a derivative of plasmid pSF151 was prepared by digestion with XbaI and PstI, followed by filling in with T4 DNA polymerase and self-ligation, resulting in pOMZ119. A 3.1-kb BamHI fragment from pALH122 harboring the lacZ gene was cloned in the BamHI site of pOMZ119 to give pOMZ125. Fragments harboring part of the gene of interest were generated by PCR amplification and cloned into the SphI/XbaI sites of plasmid pOMZ125. The resulting plasmids were introduced into S. mutans OMZ1001 by transformation, again followed by selection for kanamycin resistance. For each strain, correct integration was confirmed by PCR analysis.
Transcriptional fusions between mutated nlmAB promoter regions and lacZ were generated as follows. PCR of the region upstream of and including the prospective mutation was carried out with a primer that contained an XbaI restriction site (nlmAB10) and a primer that introduced a second restriction site and the desired mutation (Table 1). In a second PCR, the region downstream of the mutation was amplified with a primer that introduced an SphI site (nlmAB11) and a primer that introduced the same restriction site and mutation as those in the first PCR. The two PCR products were digested with the enzymes that recognized the newly created restriction sites and ligated together into pOMZ125, which had been digested with SphI and XbaI. The resulting plasmids were subsequently transformed into S. mutans. Restriction analysis of PCR products was then used to confirm that the mutation was present at the expected location.
Construction of mutants. Mutants were constructed by first cloning fragments containing portions of the 5' and the 3' ends of the gene or genes of interest up- and downstream of the erythromycin resistance gene of the plasmid pFW15 (26). The resulting plasmids were then linearized and introduced into S. mutans by transformation and selection for erythromycin resistance. The mutants were verified by PCR analysis. As summarized in Table 2 this procedure was applied to the S. mutans strains OMZ1001 and OMZ67, as well as to various derivatives of OMZ1001 containing lacZ fusions.
Specifically, a mutant of S. mutans in which part of both the comD and the comE gene was replaced by the erythromycin resistance gene was constructed as follows. A fragment was amplified by PCR using the primers comDE3 and comDE4 and chromosomal DNA from S. mutans OMZ1001. The PCR product was then digested with NcoI and PstI and cloned into the vector pFW15 to give plasmid pOMZ43. A second fragment was obtained by PCR with primers comDE1 and comDE2. This fragment was first cloned in pBluescript KS as a BamHI/XbaI fragment, recovered by digestion with BamHI and SacI, and cloned into pOMZ43 to give plasmid pOMZ61. pOMZ61 was then linearized with BamHI and introduced into S. mutans by transformation. Erythromycin-resistant colonies were selected, and one of the colonies was purified for further use. Analogously, mutants were generated, which contained a deletion/erythromycin resistance insertion in comC, ciaRH, comA, and comX. The vicK mutants were constructed by transformation of S. mutans with chromosomal DNA from strain SMUHK1, a vicK mutant obtained from D. Cvitkovitch.
ß-Galactosidase and bacteriocin assays. ß-Galactosidase was measured according to the method of Miller (17) with o-nitrophenylgalactoside as substrate.
To measure bacteriocin production, producer strains were grown overnight in THY broth, stab inoculated into THY agar, and grown anaerobically for 24 or 48 h. The indicator strains S. oralis OMZ607 and S. gordonii OMZ505 were grown overnight in THY broth, and 0.1 ml of the indicator culture was mixed with 4 ml of molten THY top agar and poured over the plate. The plates were incubated for 24 h at 37°C in an anaerobic chamber, and the diameter of the zone of inhibition around the producing strains was measured.
Determination of the transcription initiation site of bsmA. S. mutans OMZ1001 was grown to the early-exponential phase in THY at 37°C under aerobic conditions, CSP was added to a final concentration of 100 ng/ml, and growth was continued for 2 h. RNA was isolated by using the FastRNA Pro Blue kit (Qbiogene, Inc., Carlsbad, Calif.) and the FastPrep instrument (Qbiogene). For primer extension analysis, 20 pmol of primer bsmAPE (5'-GCTGTACCGCCTGCAGTAGCCATATAAC-3'), labeled at its 5' end with 6-carboxyfluorescein, was annealed with 20 µg of RNA. cDNA was produced by using Superscript II (Invitrogen, Basel, Switzerland). The product was precipitated with ethanol and dissolved in 2 µl of water, and 1 µl was loaded on an ABI Prism sequence analyzer model 3100 (Applied Biosystems, Rotkreuz, Switzerland). Fragment sizes were calculated by applying Genescan DB-30 markers (Applied Biosystems) together with the sample. To verify the size of the reverse transcriptase reaction product, a PCR was carried out with the 6-carboxyfluorescein-labeled primer bsmAPE and a second primer, using chromosomal DNA from S. mutans OMZ1001 as template. The product, which should be 200 bp in size, was applied together with the Genescan DB-30 standard. The determined product size was 197 bp. Therefore, to correct for this difference, 3 bp was added to the size determined for the reverse transcription product.
|
|
|---|
![]() View larger version (16K): [in a new window] |
FIG. 1. Induction of nlmAB'-lacZ expression by CSP. An overnight culture of S. mutans strain OMZ1008 was diluted 100-fold in fresh medium and grown aerobically at 37°C. After 4 h of growth, the culture was split and CSP was added to a final concentration of 0.5 µg/ml to one portion of the culture. The optical density at 600 nm (closed symbols) and ß-galactosidase activity (open symbols) were measured throughout growth. Circles: the culture did not receive CSP; squares, the culture received CSP. The figure shows the results of a representative experiment.
|
The amount of CSP added to the growth medium was varied from 1 ng/ml to 500 ng/ml, and ß-galactosidase activity was measured (Fig. 2). Above 5 ng/ml, an increase in ß-galactosidase activity was observed. This stimulation was linear until a CSP concentration of about 100 ng/ml. Thus, the expression of nlmAB is dependent on the amount of CSP present in the growth medium and NlmAB bacteriocin synthesis is therefore regulated as part of the comCDE quorum-sensing regulon.
![]() View larger version (10K): [in a new window] |
FIG. 2. Influence of the amount of CSP on expression of nlmAB'-lacZ. An overnight culture of S. mutans strain OMZ1008 was diluted 100-fold in fresh medium and grown aerobically at 37°C. After 4 h of growth, the culture was divided in several aliquots. Each aliquot of the culture received a different amount of CSP and was allowed to grow for another 2 hours. The activity of ß-galactosidase was then measured in each fraction. The figure shows the results of three independent experiments (indicated by circles, diamonds, and crosses).
|
|
View this table: [in a new window] |
TABLE 3. ß-Galactosidase activity expressed from a transcriptional nlmAB'-lacZ fusion in wild-type and mutant strains
|
The ciaRH genes (SMU.1128 and SMU.1129) of S. mutans encode a two-component signal transduction system that is involved in competence development. Inactivation of ciaH, encoding the histidine kinase, led to a decrease of competence (28), whereas interruption of the complete ciaRH gene cluster resulted in an increase of competence (J. R. van der Ploeg, unpublished results). Interestingly, a ciaH deletion, but not a ciaR deletion, was found to abolish production of the lantibiotic bacteriocin mutacin but had no influence on production of mutacin IV (encoded by nlmAB) (28). The ciaRH mutant investigated in this study is defective in both ciaR and ciaH, yet this mutation had no apparent effect on expression of nlmAB'-lacZ (Table 3).
Another two-component signal transduction system, encoded by vicRK, has been shown to influence competence development (D. Cvitkovitch, personal communication). The vicK gene (SMU.1516) encodes a histidine kinase, whereas vicR (SMU.1517) encodes a response regulator. When a vicK mutation was introduced into OMZ1008, the level of nlmAB'-lacZ expression in uninduced cultures was higher than in uninduced cultures of the wild-type strain (Table 3), indicating that vicK acts negatively on nlmAB expression.
Several putative bacteriocins are regulated by CSP and the comDE system. Analysis of the S. mutans genome sequence (1) revealed 10 small open reading frames with high similarity to the leader peptides of NlmA and NlmB that could encode class II bacteriocins (Fig. 3 and 4). The putative bacteriocins, designated Bsm (bacteriocin Streptococcus mutans) ranged in size from 47 to 87 amino acids, had leader peptides from 22 to 25 amino acids (Table 4 and Fig. 3), and contained a double glycine motif that could be recognized by the ComAB processing and export system. Some of the genes encoding the putative bacteriocins were located in tandem, indicating that they might act cooperatively, as is typical for class IIB bacteriocins (Table 4 and Fig. 4). Most of the putative bacteriocins were predicted to be of hydrophobic nature. Out of these putative bacteriocins, eight are encoded within a region of about 20 kb in size, which also harbors the comC, comD, and comE genes (Fig. 4) (15) Two pairs of bacteriocin-encoding genes (bsmFG and bsmHI) appear to be separated by an insertion element (Fig. 4). One of the bacteriocin-encoding genes (bsmA, SMU.1914c) is located immediately upstream of the comC gene (SMU.1915c), but in the opposite direction of transcription.
![]() View larger version (47K): [in a new window] |
FIG. 3. Clustal W sequence alignment of the leader peptide sequences of putative type II bacteriocins and CSP. Asterisk, identical residue; colon, conserved residue; period, semiconserved residue.
|
![]() View larger version (21K): [in a new window] |
FIG. 4. Genetic organization of loci harboring the bsm, imm, and competence-related genes. Genes shown by black arrows and arrowheads encode putative bacteriocins, whereas genes associated with competence and bacteriocin production are shown by shaded arrows. The scale above the maps is in base pairs. Numbers above or below the genes correspond with the numbering by Ajdic et al. (1). Incomplete genes are denoted by a prime. Vertical arrows indicate the position of the conserved direct repeat involved in ComCDE-dependent expression.
|
|
View this table: [in a new window] |
TABLE 4. Putative bacteriocins encoded by S. mutans UA159
|
|
View larger version (17K): [in a new window] |
FIG. 5. Sequence alignment of upstream regions from four genes encoding putative bacteriocins and one gene encoding a putative bacteriocin immunity protein. The direct repeat elements and the extended 10 promoter regions are underlined. The consensus sequence is shown above the sequences (nucleotides present in each of the sequences are in uppercase, and nucleotides occurring in four of the sequences are in lowercase), whereas the general consensus binding site proposed for TCSTSs of the AlgR/AgrA/LytR family (22) is given below the sequences in boldface. The start of the bsmA transcript is indicated by an arrow. The distance in nucleotides between the end of the conserved region and the start codon is shown.
|
|
View this table: [in a new window] |
TABLE 5. ß-Galactosidase activities expressed from transcriptional lacZ fusions in a wild-type background and in a comDE mutanta
|
To further confirm that the direct repeat is required for CSP-dependent expression, transcriptional lacZ fusions to genes that lacked this repeat (bsmE, bsmHI, and bsmK) were generated and ß-galactosidase was measured (Table 5). Expression of the bsmE'-lacZ and the bsmHI'-lacZ fusions was not increased by addition of CSP and not dependent on comDE. The bsmK'-lacZ fusion exhibited a small increase in ß-galactosidase activity upon addition of CSP and showed less-than-twofold-reduced levels of activity in a comDE background. It is possible that this dependence on comCDE results from expression from the bsmBL promoter, which is located about 2.3 kb upstream of bsmK and which contains a conserved direct repeat element (Fig. 4).
Mutational analysis of the nlmAB direct repeat. To substantiate the hypothesis that the direct repeat could function as a binding site for a transcriptional regulator (most likely ComE) and thus be required for CSP-dependent expression, chromosomally located transcriptional fusions between the nlmAB promoter region and lacZ were constructed. Mutations were introduced in the direct repeat element, and expression of these nlmAB'-lacZ fusions was measured in cultures that had received CSP (Fig. 6). Both mutations in repeat 2 led to approximately 10-fold-reduced levels of ß-galactosidase activity, whereas the mutation in repeat 1 resulted in 40-fold-lower levels of ß-galactosidase. Removal of both repeats and the region in between abolished expression nearly completely. These data clearly demonstrate that the direct repeat is important for full expression of nlmAB.
|
View larger version (13K): [in a new window] |
FIG. 6. Mutations in the direct repeat of the nlmAB promoter region and their effect on activity of ß-galactosidase expressed from a transcriptional nlmAB'-lacZ fusion. Direct repeats are underlined. Residues that were mutated are shown in lowercase and boldface. In S. mutans strain OMZ1037, both repeats and the region in between the repeats were deleted. Activity of ß-galactosidase was measured in late-exponential-phase cultures 3 h after addition of 100 ng/ml of CSP.
|
|
View this table: [in a new window] |
TABLE 6. Growth inhibition by S. mutans wild-type and mutant strainsa
|
|
|
|---|
Unlike competence, which exhibits an optimum during a short interval of the exponential phase (data not shown) (19, 23), expression of nlmAB'-lacZ was lowest in this period but reached a maximum in the stationary phase. Since both activities are controlled by the same regulatory system, the question arises as to how this differential regulation is established. The key to the answer may lie in the fact that expression of genes required for competence development is governed by the accessory sigma factor ComX, whereas production of bacteriocins is not, as shown in the present study. In S. pneumoniae, the comX gene, under the regulatory control of the comCDE system, is transcribed only during the first 15 min after addition of CSP, but then transcription is shut off by an unknown mechanism (25). This short period of transcription of comX, together with the short half-life of the ComX protein, results in transient expression of the late competence genes. A similar situation probably applies to S. mutans, since expression of a comX-lacZ fusion was induced only during the first minutes after addition of CSP (2). In contrast, the nlmAB'-lacZ fusion exhibited an increase of ß-galactosidase activity more than 2 h after addition of CSP.
Many of the bacteriocin-encoding genes are located in the vicinity of the comCDE genes. It is therefore likely that ComE binds to the direct repeat upstream of these genes to activate transcription of these genes, but it cannot be ruled out that ComE regulates the activity of a second transcription factor that then acts on the promoter regions of bacteriocins. In S. pneumoniae, the ComE protein binds to the promoter region of the comCDE and comAB (33), and it was expected to bind as well upstream of comX (13). However, no such binding sites in front of the S. mutans comAB, comX, comC, and comDE genes could be detected.
As many as 12 putative bacteriocins are encoded on the chromosome of S. mutans. There could be even more, as pointed out by a recent survey (7). The finding of so many type II bacteriocins raises several questions: (i) towards which species are these bacteriocins active, (ii) under what conditions are they expressed, and (iii) is the production of bacteriocins relevant for colonization or survival of S. mutans in dental plaque?
Although there is no obvious sequence similarity among the mature peptides, all putative bacteriocins from S. mutans are hydrophobic, suggesting that they interact with the bacterial cytoplasmic membrane. Since purified NlmAB bacteriocin is active against a broad range of oral streptococci (27), it is likely that the others are also directed towards these organisms. Detailed analysis with purified peptides is necessary to obtain conclusive evidence about the spectrum of the microbes that are sensitive. Class IIB bacteriocins generally act much more efficiently than two-peptide systems. It is possible that different combinations of bacteriocins have different antimicrobial spectra. The 12 peptides encoded in the genome of S. mutans would thus allow for a large repertoire.
Consistent with this hypothesis is the observation that S. mutans OMZ1001 produces bacteriocins against S. gordonii OMZ505 but not against S. oralis OMZ607, whereas S. mutans strain OMZ67 inhibited growth of OMZ607 but not of OMZ505 (results not shown), assuming heterogeneity with respect to the bacteriocins produced by these strains.
The second question concerning conditions of bacteriocin expression has been answered to some extent in this study. At least the six bacteriocins that contain the conserved upstream direct repeat element are likely to be regulated by the comCDE signal transduction system. The level of expression of nlmAB was found to be dependent on the concentration of CSP. It is not known how expression of the comC gene is regulated in S. mutans, but it seems likely that the concentration of CSP reaches its maximum in the stationary phase. Growth in biofilms is also expected to lead to high concentrations of CSP. Indeed, when strains were grown on plates, conditions comparable to growth, expression of nlmAB'-lacZ was higher than when strains were grown in liquid cultures. This correlates with the observation that addition of CSP to plates did not lead to a large increase of bacteriocin production by the wild-type strain, whereas ß-galactosidase activities were strongly increased upon addition of CSP in liquid cultures. My results appear to contrast with those of Qi et al., who found higher expression of nlmAB in liquid cultures than on plates (27). Recently, it was shown that S. mutans GS-5, which is the same as strain OMZ67 used in this study, produces a two-peptide lantibiotic bacteriocin named Smb. Expression of the smb operon that encodes the bacteriocin structural proteins, immunity, processing, and transport were found to be dependent on the comCDE system (36). The promoter region of this operon contained a very similar direct repeat element as described here. Thus, the comCDE system appears to regulate nonlantibiotic as well as lantibiotic bacteriocin synthesis.
Derivatives of strain OMZ1001 and OMZ67 deficient in comA, comC, or comDE lost the ability to inhibit growth of S. gordonii OMZ505 and S. oralis OMZ607, respectively. This can likely be ascribed to the loss in expression of the bacteriocin genes that contain the direct repeat region. But these mutants may have kept the ability to produce one or more of the remaining bacteriocins. The observation that the com mutants did not inhibit growth of indicator strains suggests either that these remaining bacteriocins are not expressed under the conditions investigated or that they are expressed but active against other organisms. The latter explanation appears most likely, since the bsmE, bsmK, and bsmHI genes were expressed when S. mutans was grown in liquid medium.
The loss of growth inhibition by the comA mutant of OMZ1001 could not be complemented by addition of CSP. This suggests that, at least in this strain, processing and export of CSP and bacteriocins are carried out by the same transport proteins. This is not completely unexpected, since the N-terminal sequences of the bacteriocins and that of CSP are similar in size and sequence (Fig. 3). The existence of a unique transporter for bacteriocins and for the inducing peptide has also been proposed for bacteriocin production by Lactobacillus sakei (5). The comA mutant of strain OMZ67 could be complemented by addition of CSP. It might well be that processing and export of the lantibiotic bacteriocin Smb produced by this strain require a specific protein. Indeed, a gene that could encode a bacteriocin transporter was present in the smb operon (36).
What is the link between competence, biofilm formation, and bacteriocin production? Several studies have shown that oral streptococci lacking one of the components of the comCDE system produce poorer or differently structured biofilms (15, 16). In Streptococcus intermedius, biofilm formation was stimulated by addition of CSP (24). This stimulation was detectable at CSP concentrations that were in the same range as the concentrations required for induction of expression of nlmAB'-lacZ. In addition, competence of S. mutans was found to be increased when grown in biofilms (14). Other studies have also suggested a connection between competence and bacteriocin production. In Bacillus subtilis, production of the dipeptide bacilysin was regulated by the system required for genetic competence (35). In S. pneumoniae, genes encoding bacteriocins are also induced by CSP and regulated by comDE, but they belong to the late-induced genes. The late-induced genes do not contain a direct repeat sequence that could act as a binding site for ComE but instead require ComX and have a conserved element (TACGAATA) just upstream of the transcription start site (13). This element could not be detected upstream of the genes encoding bacteriocins in S. mutans.
It has been shown recently that S. pneumoniae releases chromosomal DNA after addition of CSP and that this DNA release is dependent on ComD and ComE (18). Interestingly, the highest amounts of DNA were released in the stationary phase of growth, which coincides with the maximum in expression of bacteriocins in S. mutans. Although a speculative hypothesis, it is possible that bacteriocins produced during the stationary phase aid in release of DNA either from S. mutans itself or from competing streptococci by permeabilization of the cytoplasmic membrane. The DNA that is liberated could serve several functions. First, it might function as a component of a biofilm structure. It has recently been shown that addition of DNase inhibited biofilm formation of S. intermedius and Pseudomonas aeruginosa (24, 34), indicating that DNA contributes to biofilm development. Second, the DNA, and possibly other cellular constituents, might fulfill a nutritional requirement for starving cells (8). The "classical" role of competence development, uptake of DNA and subsequent recombination to increase the fitness, remains as a third possibility.
This work was supported by a grant from the University of Zürich.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»